Nicotinamide adenine dinucleotide (NAD+) intravenous therapy benefits
Pro Research Analysisby 
Searched over 200M research papers
NAD+ Intravenous Therapy: Safety and General Benefits
Research shows that increasing nicotinamide adenine dinucleotide (NAD+) levels can help slow age-related disease progression and promote healthier aging. Intravenous (IV) administration of NAD+ or its precursors, such as nicotinamide mononucleotide (NMN), has been found to be safe in both animal and human studies, with no significant adverse effects on vital signs or organ function markers Kimura2022Zheng2022. These therapies efficiently raise blood NAD+ levels, which is important for cellular energy, DNA repair, and metabolic health Kimura2022Braidy2020Abdellatif2021.
Cardiometabolic Health: Cholesterol, Triglycerides, and Blood Pressure
IV NAD+ therapy and NMN supplementation have shown significant benefits for cardiometabolic health. Studies in healthy adults and those at risk for age-related conditions found that NAD+ augmentation can lower blood triglyceride levels, total cholesterol, LDL cholesterol, and diastolic blood pressure Kimura2022Pencina2023. These changes suggest a potential role for NAD+ therapy in preventing or treating conditions like fatty liver, diabetes, and cardiovascular disease Kimura2022Pencina2023Abdellatif2021.
Heart Failure and Cardiac Function
NAD+ is crucial for heart cell energy metabolism and redox balance. In patients with heart failure, IV NAD+ therapy for seven days improved markers of cardiac function, reduced oxidative stress, and lessened endothelial injury compared to placebo, although some improvements were not statistically significant . Preclinical and clinical studies support the idea that boosting NAD+ levels can protect the heart, improve mitochondrial function, and reduce inflammation and oxidative stress, which are key factors in heart failure and other cardiac diseases Pei2024Walker2024Abdellatif2021.
Neuroprotection and Brain Health
Animal studies show that IV NMN can enter the brain, increase NAD+ levels, and protect against brain damage after ischemic stroke by reducing infarct size and supporting neuronal survival Zheng2022Park2016. These findings suggest that NAD+ therapy may have neuroprotective effects, especially in conditions involving acute brain injury or neurodegeneration Zheng2022Park2016.
Anti-Inflammatory and Regenerative Effects
Combining IV NAD+ with umbilical cord-derived stem cells (UCSCs) has been shown to enhance tissue repair, reduce inflammation, and lower oxidative stress. This combination activates sirtuins, proteins involved in cellular health and longevity, and may further boost the regenerative and anti-inflammatory benefits of NAD+ therapy .
Mechanisms and Metabolism of IV NAD+ Therapy
During IV infusion, NAD+ is rapidly metabolized and removed from plasma, with its breakdown products excreted in urine. This rapid metabolism highlights the need for optimized dosing strategies to maintain therapeutic NAD+ levels . NAD+ therapy works by supporting energy production, DNA repair, and reducing chronic oxidative stress and inflammation, which are common in aging and degenerative diseases Braidy2020Abdellatif2021.
Safety and Risks
Most studies report that IV NAD+ and its precursors have a favorable safety profile with minimal acute toxicity Kimura2022Zheng2022Braidy2020+1 MORE. However, long-term safety data in humans are still limited, and potential risks such as accumulation of toxic metabolites or effects on tumor growth require further investigation .
Conclusion
IV NAD+ therapy and its precursors, especially NMN, are safe and show promise for improving cardiometabolic health, supporting heart and brain function, and reducing inflammation and oxidative stress. While early results are encouraging, more large-scale and long-term clinical trials are needed to fully understand the benefits and risks of NAD+ intravenous therapy in humans.
Sources and full results
Most relevant research papers on this topic